PSCK9 inhibitors reduced early recurrent stroke in patients with symptomatic intracranial atherosclerotic stenosis. Wu L, Zhang B, Li C, Zhuang Z, et al. J Neurol Neurosurg Psychiatry 2024 Jan 11:jnnp-2023-332392.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu L, Zhang B, Li C, Zhuang Z, et al. PSCK9 inhibitors reduced early recurrent stroke in patients with symptomatic intracranial atherosclerotic stenosis. J Neurol Neurosurg Psychiatry 2024 Jan 11:jnnp-2023-332392.
PMID: 38212060